Nordic Group is a privately owned pan-European pharmaceutical company with a presence in 17 countries.
It focuses on the development and commercialisation of niche hospital, and orphan products to respond to unmet medical needs. Nordic Group expertise relies on the development and sales of its own products, but also on partner products acquired at various stages of development.
Nordic Group marketing & sales activities are operated in Europe under two different corporate identities
Nordic Drugs operates in the four major Scandinavian
countries i.e. Sweden, Denmark, Norway and Finland.
Nordic Drugs particularly focuses on the primary care
and retail pharmacy markets, but it is as well increasingly present in the
secondary care market. Nordic Drugs has a portfolio of pharmaceutical
specialties, branded generics and a range of OTC products.
Nordic Pharma is focusing its activities to the specialists and hospital
markets in Western, Central & Eastern Europe and South Europe, and in particular in the United Kingdom, Ireland, France, The Netherlands,
Belgium, Germany, Austria, Switzerland, Italy, Spain,
Czech Republic, Slovakia and Poland.
Nordic Group has always maintained a tradition of developing successful partnerships with third parties in addition
to its own development projects. Nordic Group also offers US, Japanese and other non-European companies
the opportunity to take advantage of Nordic's knowledge of the European markets and forges broad
partnerships to develop, register and commercialise their products in Europe. Marketing
and Sale entities are supported by services companies in the group.
Nordic aims at developing products that address unmet medical needs to healthcare professionals and patients. Today, Nordic has a range of highly specialised proprietary and in-licensed products in the following therapeutic areas:
Rheumatology
Gynaecology
Anaesthesia
Haematology
Oncology
Nordic Group has affiliates in most European countries and has set up partnerships to promote and distribute its products throughout the world
254, bd Saint-Germain, 75007 Paris
Tel : +33 1 70 37 28 00
info@nordicpharma.com
business.development@nordicpharma.com
Consumers and Health care professionals are encouraged to report
any adverse drug reaction that may have occurred after a Nordic Pharma drug intake to,
pv@nordicpharma.com or, and to health authorities http://www.adrreports.eu/
INFORMATION COVID-19
In this period of pandemic crisis, we are aware of our responsibility towards patients and healthcare professionals.
Nordic Pharma is therefore taking appropriate measures to guarantee patients continuous access to their treatment. Our organization makes every effort to ensure the supply of our medicines and medical devices, while guaranteeing the safety and health of all the employees involved.
As always, Nordic Pharma operates under the guidelines of local government and public health authorities.
We have set up numerous remote cooperation measures so that our employees can communicate with each other and with you. We continue to work tirelessly to stay at your service.
Please do not hesitate to contact your local Nordic Pharma team if you have any questions or concerns.
Nordic Pharma would like to thank all the medical staff, all the caregivers and all those who, in these times, care about the well-being of others. We wish to express our deep respect.
The Nordic Pharma management team meets continuously to assess the situation and react appropriately as the crisis evolves. We will keep you informed via this page.